Why is Mavyret so Hard to Find? [Explained for 2026]

If you've been prescribed Mavyret (glecaprevir/pibrentasvir) for hepatitis C, you may have discovered that picking it up isn't always as simple as dropping off a prescription. Despite not appearing on the FDA's official drug shortage list, patients across the country report difficulty locating Mavyret at their local pharmacy. Here's a clear explanation of why that happens—and what you can do right now.

Is Mavyret Actually in a Shortage?

No—Mavyret is not currently listed on the FDA's drug shortage database as of 2026. AbbVie continues to manufacture and supply the drug. The challenge isn't a manufacturing crisis; it's a combination of how the drug is dispensed, how insurance works, and the specialized nature of hepatitis C treatment.

That said, "not in a national shortage" doesn't mean "easy to find at every pharmacy." For many patients, Mavyret might as well be in short supply because their nearest pharmacy simply doesn't stock it—or doesn't stock it consistently.

Why Doesn't My Local Pharmacy Have Mavyret?

Mavyret is an expensive specialty medication—an 8-week supply (84 tablets) has a retail price between $14,000 and $17,000. Because of its high cost and the need for insurance verification and prior authorization, Mavyret is often categorized as a specialty drug. This affects where and how it gets stocked.

Here are the main reasons patients struggle to find Mavyret at the counter:

Specialty pharmacy routing: Many insurance plans, including Medicare Part D, require Mavyret to be dispensed through a designated specialty pharmacy rather than your neighborhood drugstore. Your prescription may need to be rerouted.

Prior authorization delays: Most insurance plans require prior authorization (PA) before covering Mavyret. Until PA is approved, the pharmacy can't dispense the drug even if it's on the shelf.

Low stocking volume: Because hepatitis C prescriptions are relatively infrequent at most retail pharmacies, many stores don't carry Mavyret in stock. They order it only when a prescription arrives—and that takes time.

Inventory doesn't match demand: Even at pharmacies that do stock Mavyret, inventory levels fluctuate. A single large prescription can clear out a month's supply.

The Prior Authorization Problem

Prior authorization is one of the biggest barriers for Mavyret patients. Here's how it typically works: your doctor sends the prescription, then must separately submit clinical documentation to your insurance company proving that Mavyret is medically necessary for you. This process can take anywhere from 3 to 14 days—sometimes longer if your insurer requests additional information.

During this waiting period, the pharmacy holds your prescription but cannot dispense it. If your insurer denies the PA (which can happen due to step therapy requirements, incomplete documentation, or other reasons), you may need to appeal or try an alternative drug first.

To speed things up, ask your doctor's office to proactively start the PA process before you try to fill the prescription. Many hepatitis C specialists have dedicated staff who handle this routinely.

Does the Specialty Pharmacy Requirement Apply to Me?

It depends on your insurance plan. Many commercial insurers and Medicare Part D plans designate Mavyret as a specialty-tier drug, which means it must be filled at a contracted specialty pharmacy (like Accredo, CVS Specialty, or Walgreens Specialty Pharmacy). Retail pharmacies—even large chains—may not be authorized to dispense it under your plan.

If you're paying cash or using a manufacturer's savings card, you typically don't face this restriction and can use any pharmacy that can order or stock Mavyret.

What About Patients Who Don't Have Insurance?

Without insurance, Mavyret's cash price is well over $14,000 for an 8-week supply. That puts it out of reach for most patients paying out of pocket. However, AbbVie's myAbbVie Assist program provides Mavyret at no cost to eligible uninsured or underinsured patients who meet income requirements. You can reach myAbbVie Assist at 1-800-222-6885.

The HealthWell Foundation and the Good Days Patient Assistance Program also offer financial support for hepatitis C medications. These programs can make Mavyret accessible even for patients with limited or no coverage.

Why Timing Matters: Hepatitis C Can't Wait

Unlike many conditions where delays are inconvenient but not urgent, hepatitis C is a progressive disease. Untreated, it can cause irreversible liver scarring (cirrhosis) and increase the risk of liver cancer over time. The newer the infection (acute phase), the greater the benefit of early treatment—Mavyret is now the first and only direct-acting antiviral approved to treat acute HCV, with a 96% cure rate at 8 weeks.

Delays caused by insurance barriers, pharmacy routing issues, or difficulty locating stock can have real medical consequences. Acting quickly to resolve filling barriers is medically important—not just a matter of convenience.

How to Find a Pharmacy With Mavyret in Stock

Rather than calling pharmacies one at a time—which is time-consuming and often fruitless—medfinder does the calling for you. You provide your medication, dosage, and location, and medfinder contacts pharmacies near you to find out which ones can fill your Mavyret prescription. Results are texted directly to you.

You can learn more at medfinder.com. It's also worth reading our guide: How to find Mavyret in stock near you.

Key Takeaways

Mavyret is NOT in a national FDA shortage as of 2026

Most filling difficulties stem from specialty pharmacy routing and prior authorization requirements

Many retail pharmacies don't stock Mavyret because of its high cost and infrequent demand

Patient assistance programs exist for uninsured or underinsured patients

Tools like medfinder can help you identify which pharmacies near you can actually fill your prescription

If you're having persistent trouble filling Mavyret, it's also worth discussing alternatives to Mavyret with your doctor—drugs like Epclusa (sofosbuvir/velpatasvir) may be available at more pharmacies or at lower cost with a generic.